XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2018
Dec. 31, 2017
ASSETS    
Cash and cash equivalents $ 571,154 $ 312,727
Grant funds and other receivables 5,000 59,758
Prepaid expenses and other current assets 226,170 75,589
Total current assets 802,324 448,074
Property and equipment, net 26,171 31,151
Deposits 11,010 11,010
Total assets 839,505 490,235
Current liabilities:    
Accounts payable 54,039 77,581
Accrued expenses (Note 6) 864,358 733,711
Current portion of note payable 1,042
Total current liabilities 919,439 811,292
Note payable, net of current portion 48,958
Total liabilities 968,397 811,292
Commitments (Note 8)
Stockholders’ equity (deficiency):    
Common stock, $.001 par value: Authorized shares – 600,000,000 Issued and outstanding shares – 141,736,810 and 106,736,810 at March 31, 2018 and December 31, 2017 141,737 106,737
Additional paid-in capital 36,219,889 35,589,911
Accumulated deficit (38,538,603) (37,916,790)
Total stockholders’ equity (deficiency) (128,892) (321,057)
Total liabilities and stockholders’ equity (deficiency) 839,505 490,235
Series B Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 76,095 76,095
Series C Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 842,990 842,990
Series D Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 539,000 980,000
Series E Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock $ 590,000